
Takara Bio Europe has entered into a distribution agreement with Macherey-Nagel (MN), an analytical and bioanalytical product provider, to expand …

Kynos Therapeutics โ a Scottish clinical stage biopharma company focusing on developing novel kynurenine 3-monooxygenase (KMO) inhibitors โ has been …

This week, drug discovery company Cresset has announced the extension of its global collaboration with chemical and biological contract research …

leading life science investor Novo Holdings, announced a ยฃ50m investment in Oxford Nanopore Technologies. Oxford Nanopore Technologies is a leading …

Portfolio therapeutics company Apollo Therapeutics has announced earlier this week that it will provide capital and expertise to Oxford Universityโs …

GSK has announced that it has pledged ยฃ45m to the Fleming Initiative, becoming the first founding partner of the innovative …

On 30August 2023, CN Bio announced the appointment of Dr Tomasz Kostrzewski as chief scientific officer (CSO) – a new …

The European Parliament has shared its recommendations for a โcoordinated EU response to health threats posed by antimicrobial resistance,โ according …

Scientists at McMaster University and the Massachusetts Institute of Technology (MIT) have utilised artificial intelligence (AI) in order to discover …